AI could help babies avoid unnecessary kidney surgery

NCT ID NCT07581223

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an AI tool that analyzes ultrasound images to help doctors decide if a baby with hydronephrosis (kidney swelling) needs surgery. About 322 infants up to 24 months old will take part. Doctors first make a care plan without the AI, then see the AI's prediction and can change their plan. A separate expert makes the final decision to ensure safety. The goal is to see if the AI improves decision-making and reduces the need for invasive tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

AI-driven decision-making tool (machine learning model)

What this could lead to

If successful, this AI tool could help doctors make faster, more accurate decisions about whether a baby with kidney swelling needs surgery, reducing unnecessary invasive tests.

What could go wrong

This is an early-stage study testing how well the AI fits into real-world care. It may not improve decisions or could be difficult to integrate into busy clinics.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYDRONEPHROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital hydronephrosis hydronephrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.